ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
79.285
0.00%
US Dollar vs AUD
1.6276
0.00%
Bitcoin
94,251.36
-0.48%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. MoonLake Immunotherapeutics (MLTX) Share Price

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX)

NASDAQ
46.315
-1.86
(-3.85%)
Closed 11 January 8:00AM
Delayed by 15 minutes
46.315
0.015
(0.03%)
After Hours: 10:41AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
46.315
Bid
45.80
Offer
49.67
Volume
443,893
46.00 Day's Range 48.865
37.55 52 Week Range 64.98
Market Cap
2.96B
Previous Close
48.17
Open
48.00
Last Trade
1
@
46
Last Trade Time
Financial Volume
US$ 21,073,139
VWAP
47.4735
Average Volume (3m)
230,288
Shares Outstanding
63,905,198
Dividend Yield
-
PE Ratio
-67.12
Earnings Per Share (EPS)
-0.69
Revenue
-
Net Profit
-44.08M

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector
Blank Checks
Industry
Pharmaceutical Preparations
Website
moonlaketx.com
Headquarters
Grand Cayman, Cym
Founded
2020
MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was US$48.17. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of US$ 37.55 to US$ 64.98.

MoonLake Immunotherapeut... currently has 63,905,198 shares in issue. The market capitalisation of MoonLake Immunotherapeut... is US$3.08 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -67.12.

Ask ADVFN Intelligence (AI)

MLTX Latest News

More News

MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis suppurativa (HS), Phase 2 LEDA trial in palmoplantar...

08 January 2025
GlobeNewswire Inc.

Form 8-K - Current report

19 December 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

14 November 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term...

07 November 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

09 October 2024
Edgar (US Regulatory)

Form 8-K - Current report

11 September 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

09 September 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 August 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-7.245-13.526885735653.5655.0146.353447050.4923229CS
4-7.555-14.024503434253.8758.2646.329173952.1459413CS
12-1.765-3.6709650582448.0858.2645.2423028851.12069437CS
261.3252.9450989108744.9958.2639.3629639249.37712531CS
52-12.485-21.232993197358.864.9837.5535064548.6271828CS
15633.945274.41390460812.3764.984.2534378443.13745243CS
26033.945274.41390460812.3764.984.2534378443.13745243CS

MLTX - Frequently Asked Questions (FAQ)

What is the current MoonLake Immunotherapeut... share price?
The current share price of MoonLake Immunotherapeut... is US$ 46.315
How many MoonLake Immunotherapeut... shares are in issue?
MoonLake Immunotherapeut... has 63,905,198 shares in issue
What is the market cap of MoonLake Immunotherapeut...?
The market capitalisation of MoonLake Immunotherapeut... is USD 3.08B
What is the 1 year trading range for MoonLake Immunotherapeut... share price?
MoonLake Immunotherapeut... has traded in the range of US$ 37.55 to US$ 64.98 during the past year
What is the PE ratio of MoonLake Immunotherapeut...?
The price to earnings ratio of MoonLake Immunotherapeut... is -67.12
What is the reporting currency for MoonLake Immunotherapeut...?
MoonLake Immunotherapeut... reports financial results in USD
What is the latest annual profit for MoonLake Immunotherapeut...?
The latest annual profit of MoonLake Immunotherapeut... is USD -44.08M
What is the registered address of MoonLake Immunotherapeut...?
The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104
What is the MoonLake Immunotherapeut... website address?
The website address for MoonLake Immunotherapeut... is moonlaketx.com
Which industry sector does MoonLake Immunotherapeut... operate in?
MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

MLTX Discussion

View Posts
Monksdream Monksdream 4 months ago
MLTX in an up trend
👍️0
AKATITUS AKATITUS 1 year ago
Sleeping
Come on 70.00
👍️0
Monksdream Monksdream 1 year ago
MLTX new 52 week high
👍️0
AKATITUS AKATITUS 2 years ago
Haha. Now that's funny. 18,000 share buy at 52.00 dollars.
👍️0
AKATITUS AKATITUS 2 years ago
Damm some big buys at 54.00 WoW
👍️0
AKATITUS AKATITUS 2 years ago
Hope it busts soon.
👍️0
AKATITUS AKATITUS 2 years ago
Looks like a good churning. Will tomorrow be the same. ??????
👍️0
MiamiGent MiamiGent 2 years ago
MLTX Started the day with a bang. Falling back, presently

MOONLAKE IMMUNOTHERAPEUTICS
$41.80 +15.92 (+61.51%)
As of Jun-26-202310:46:16 AM ET

https://stockcharts.com/h-sc/ui?s=MLTX

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
BENZINGA
31 mins ago
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today's session.

MoonLake Immunotherapeutics (NASDAQ:MLTX) jumped 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.

(con't)
👍️0
AKATITUS AKATITUS 2 years ago
So pissed I was trying to sell somethings to buy 40ts them boom 100 bucks F##########
👍️0
Awl416 Awl416 2 years ago
Crazy
👍️0
crudeoil24 crudeoil24 3 years ago
MoonLake Immunotherapeutics (NASDAQ: MLTX) 10% owner Bihua Chen acquired a total of 5,635,000 shares at an average price of $10.00. To acquire these shares, it cost around $28.5 million.
👍️0

Your Recent History

NASDAQ
MLTX
MoonLake Immunotherapeut...
NASDAQ
FDHSX
Bmo Equity Growth Etf Po...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads